Doyle Mittie

CIK 00019188453 companiesWAYNE, PA

SEC Profile

Transactions

Companies

Filings

CIK

0001918845

Recent Transactions

49 trades

Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-06-30$12.65/sh+2,875→ 54,651 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2026-06-30−1,779→ 115,092 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2026-06-30−2,875→ 125,750 total
Sale
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-06-30$20.00/sh−4,654→ 51,776 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-06-30$8.04/sh+1,779→ 56,430 total
Sale
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-06-23$18.00/sh−1,450→ 51,776 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2026-06-23−1,450→ 116,871 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-06-23$8.04/sh+1,450→ 53,226 total
Award
Cullinan Therapeutics, Inc.$CGEM
Stock Option (Right to Buy)
2026-06-16+21,781→ 21,781 total
Tax Payment
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-06-10$13.10/sh−1,084→ 51,776 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-05-28$8.04/sh+679→ 47,801 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2026-05-28−679→ 118,321 total
Sale
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-05-28$16.00/sh−679→ 47,122 total
Award
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-05-21+43,500→ 47,122 total
Sale
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-05-15$18.76/sh−3,000→ 3,622 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2026-05-15−3,000→ 128,625 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-05-15$12.65/sh+3,000→ 6,622 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2026-05-06−77,905→ 131,625 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-05-06$12.65/sh+77,905→ 81,527 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-05-06$8.04/sh+28,650→ 110,177 total
Sale
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-05-06$18.03/sh−27,538→ 82,639 total
Sale
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-05-06$19.65/sh−5,000→ 77,639 total
Sale
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-05-06$21.20/sh−44,944→ 32,695 total
Sale
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-05-06$22.41/sh−19,015→ 13,680 total
Sale
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-05-06$22.88/sh−10,058→ 3,622 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2026-05-06−28,650→ 119,000 total
Sale
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-05-05$16.00/sh−1,679→ 3,622 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2026-05-05−1,000→ 209,530 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2026-05-05−679→ 147,650 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-05-05$12.65/sh+1,000→ 4,622 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-05-05$8.04/sh+679→ 5,301 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2026-04-06−3,970→ 210,530 total
Sale
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-04-06$18.01/sh−3,970→ 3,622 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-04-06$12.65/sh+3,970→ 7,592 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-04-01$8.04/sh+679→ 4,301 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2026-04-01−679→ 148,329 total
Sale
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-04-01$16.00/sh−679→ 3,622 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-03-16$12.65/sh+19,500→ 23,122 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2026-03-16−5,992→ 149,008 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-03-16$8.04/sh+5,992→ 29,114 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2026-03-16−19,500→ 214,500 total
Sale
Avalo Therapeutics, Inc.$AVTX
Common Stock
2026-03-16$16.15/sh−25,492→ 3,622 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2026-02-26+105,000→ 105,000 total
Tax Payment
Avalo Therapeutics, Inc.$AVTX
Common Stock
2025-12-10$4.10/sh−1,013→ 3,622 total
Award
Cullinan Therapeutics, Inc.$CGEM
Stock Option (Right to Buy)
2025-08-07+79,456→ 79,456 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2025-01-28+155,000→ 155,000 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2024-07-15+234,000→ 234,000 total
Disposition to Issuer
DICE Therapeutics, Inc.
Stock Option (right to buy)
2023-08-09−42,500→ 0 total
Award
DICE Therapeutics, Inc.
Stock Option (right to buy)
2022-03-31+42,500→ 42,500 total

Companies

Recent Filings

Address

C/O AVALO THERAPEUTICS, INC. 1500 LIBERTY RIDGE DRIVE, SUITE 321

WAYNE, PA, 19087

View on SEC.gov